Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets

BACKGROUND: Bromodomain and extracellular terminal (BET) family (including BRD2, BRD3, and BRD4) is considered to be a major driver of cancer cell growth and a new target for cancer therapy. Currently, more than 30 targeted inhibitors have shown significant inhibitory effects against various tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Situ, Yongli, Liang, Quanyan, Zeng, Ziying, Chen, Jv, Shao, Zheng, Xu, Qinying, Lu, Xiaoyong, Cui, Yongshi, Zhang, Juying, Lu, Lingling, Deng, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922706/
https://www.ncbi.nlm.nih.gov/pubmed/36793283
http://dx.doi.org/10.3389/fendo.2023.1089531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922706/
https://www.ncbi.nlm.nih.gov/pubmed/36793283
http://dx.doi.org/10.3389/fendo.2023.1089531

Ejemplares similares